Methotrexate High Dose Special Investigation

על הניסוי

This Investigation is to be performed for the purpose of assessing the following information in the long-term post-marketing daily medical practice in the patients who receive REUMATOLEX 2 mg Capsule for the treatment of Rheumatoid Arthritis (RA) at the dose higher than 8 mg/week. 1. Condition of occurrence of ADRs 2. Factors considered to affect safety 3. Verification of efficacy

צפו ב-NCT01414257 ב-ClinicalTrials.gov ←

קישורים קשורים